Bacteremia due to extended-spectrum-β-lactamase-producing Enterobacter cloacae: Role of carbapenem therapy

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 9, 2010, Pages 3551-3556

  Lee, Ching Chi ^a,b   Lee, Nan Yao ^a   Yan, Jing Jou ^a,c   Lee, Hsin Chun ^a,b,c   Chen, Po Lin ^a,b   Chang, Chia Ming ^a   Wu, Chi Jung ^a,b   Ko, Nai Ying ^a,c   Wang, Li Rong ^a   Chi, H Hsien ^a,c   Ko, Wen Chien ^a,c,d  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b Institute of Clinical Medicine   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE INHIBITOR; CARBAPENEM; CEFOTAXIME; CEPHALOSPORIN DERIVATIVE; EXTENDED SPECTRUM BETA LACTAMASE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UREIDOPENICILLIN DERIVATIVE;

ADULT; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; BLOOD CULTURE; CONTROL GROUP; CONTROLLED STUDY; DISEASE SEVERITY; ENTEROBACTER CLOACAE; FEMALE; FOLLOW UP; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; SEPSIS;

AGED; AGED, 80 AND OVER; BACTEREMIA; BETA-LACTAMASES; CARBAPENEMS; ENTEROBACTER CLOACAE; HUMANS; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 77956129671     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00055-10     Document Type: Article

References (28)

1. Bell, J. M., J. D. Turnidge, and R. N. Jones. 2003. Prevalence of extended-spectrum beta-lactamase-producing Enterobacter cloacae in the Asia-Pacific region: results from the SENTRY Antimicrobial Surveillance Program, 1998 to 2001. Antimicrob. Agents Chemother. 47:3989-3993.
2. Canton, R., A. Oliver, T. M. Coque, C. Varela Mdel, J. C. Perez-Diaz, and F. Baquero. 2002. Epidemiology of extended-spectrum beta-lactamase-producing Enterobacter isolates in a Spanish hospital during a 12-year period. J. Clin. Microbiol. 40:1237-1243.
3. Chia, J. H., C. Chu, L. H. Su, C. H. Chiu, A. J. Kuo, C. F. Sun, and T. L. Wu. 2005. Development of a multiplex PCR and SHV melting-curve mutation detection system for detection of some SHV and CTX-M beta-lactamases of Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae in Taiwan. J. Clin. Microbiol. 43:4486-4491.
4. Choi, S. H., J. E. Lee, S. J. Park, M. N. Kim, E. J. Choo, Y. G. Kwak, J. Y. Jeong, J. H. Woo, N. J. Kim, and Y. S. Kim. 2007. Prevalence, microbiology, and clinical characteristics of extended-spectrum beta-lactamase-producing Enterobacter spp., Serratia marcescens, Citrobacter freundii, and Morganella morganii in Korea. Eur. J. Clin. Microbiol. Infect. Dis. 26:557-561.
5. Chow, J. W., M. J. Fine, D. M. Shlaes, J. P. Quinn, D. C. Hooper, M. P. Johnson, R. Ramphal, M. M. Wagener, D. K. Miyashiro, and V. L. Yu. 1991. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann. Intern. Med. 115:585-590.
6. Clinical and Laboratory Standards Institute. 2008. Performance standards for antimicrobial susceptibility tests; 16th informational supplement. CLSI M100-S16. Clinical and Laboratory Standards Institute, Wayne, PA.
7. Garner, J. S., W. R. Jarvis, T. G. Emori, T. C. Horan, and J. M. Hughes. 1988. CDC definitions for nosocomial infections, 1988. Am. J. Infect. Control 16:128-140.
8. Gilbert, David N., R. C. Moellering, Jr., George M. Eliopoulos, Henry F. Chambers, and Michael S. Saag (ed.). 2009. The Sanford guide to antimicrobial therapy. Antimicrobial Therapy Inc., Sperryville, VA.
9. Ho, P. L., R. H. Shek, K. H. Chow, R. S. Duan, G. C. Mak, E. L. Lai, W. C. Yam, K. W. Tsang, and W. M. Lai. 2005. Detection and characterization of extended-spectrum beta-lactamases among bloodstream isolates of Enterobacter spp. in Hong Kong, 2000-2002. J. Antimicrob. Chemother. 55:326-332.
10. Jacoby, G. A., and L. S. Munoz-Price. 2005. The new beta-lactamases. N. Engl. J. Med. 352:380-391.
11. Lautenbach, E., J. B. Patel, W. B. Bilker, P. H. Edelstein, and N. O. Fishman. 2001. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin. Infect. Dis. 32:1162-1171.
12. Lee, C. C., W. J. Lin, H. I. Shih, C. J. Wu, P. L. Chen, H. C. Lee, N. Y. Lee, C. M. Chang, L. R. Wang, and W. C. Ko. 2007. Clinical significance of potential contaminants in blood cultures among patients in a medical center. J. Microbiol. Immunol. Infect. 40:438-444.
13. Liappis, A. P., V. L. Kan, C. G. Rochester, and G. L. Simon. 2001. The effect of statins on mortality in patients with bacteremia. Clin. Infect. Dis. 33:1352-1357.
14. Ma, L., F. Y. Chang, C. P. Fung, T. L. Chen, J. C. Lin, P. L. Lu, L. Y. Huang, J. C. Chang, and L. K. Siu. 2005. Variety of TEM-, SHV-, and CTX-M-type beta-lactamases present in recent clinical isolates of Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae from Taiwan. Microb. Drug Resist. 11:31-39.
15. Marcos, M., A. Inurrieta, A. Soriano, J. A. Martinez, M. Almela, F. Marco, and J. Mensa. 2008. Effect of antimicrobial therapy on mortality in 377 episodes of Enterobacter spp. bacteraemia. J. Antimicrob. Chemother. 62: 397-403.
16. Pai, H., J. Y. Hong, J. H. Byeon, Y. K. Kim, and H. J. Lee. 2004. High prevalence of extended-spectrum beta-lactamase-producing strains among blood isolates of Enterobacter spp. collected in a tertiary hospital during an 8-year period and their antimicrobial susceptibility patterns. Antimicrob. Agents Chemother. 48:3159-3161.
17. Paterson, D. L., and R. A. Bonomo. 2005. Extended-spectrum beta-lactamases: a clinical update. Clin. Microbiol. Rev. 18:657-686.
18. Paterson, D. L., W. C. Ko, A. Von Gottberg, S. Mohapatra, J. M. Casellas, H. Goossens, L. Mulazimoglu, G. Trenholme, K. P. Klugman, R. A. Bonomo, L. B. Rice, M. M. Wagener, J. G. McCormack, and V. L. Yu. 2004. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial infections. Ann. Intern. Med. 140:26-32.
19. Pitout, J. D., M. D. Reisbig, E. C. Venter, D. L. Church, and N. D. Hanson. 2003. Modification of the double-disk test for detection of enterobacteriaceae producing extended-spectrum and AmpC beta-lactamases. J. Clin. Microbiol. 41:3933-3935.
20. Rupp, M. E., and P. D. Fey. 2003. Extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae: considerations for diagnosis, prevention and drug treatment. Drugs 63:353-365.
21. Sanders, W. E., Jr., and C. C. Sanders. 1997. Enterobacter spp.: pathogens poised to flourish at the turn of the century. Clin. Microbiol. Rev. 10:220-241.
22. Schellevis, F. G., J. van der Velden, E. van de Lisdonk, J. T. van Eijk, and C. van Weel. 1993. Comorbidity of chronic diseases in general practice. J. Clin. Epidemiol. 46:469-473.
23. Schlesinger, J., S. Navon-Venezia, I. Chmelnitsky, O. Hammer-Munz, A. Leavitt, H. S. Gold, M. J. Schwaber, and Y. Carmeli. 2005. Extended-spectrum beta-lactamases among Enterobacter isolates obtained in Tel Aviv, Israel. Antimicrob. Agents Chemother. 49:1150-1156.
24. Sturenburg, E., I. Sobottka, D. Noor, R. Laufs, and D. Mack. 2004. Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum beta-lactamases in an Enterobacteriaceae strain collection. J. Antimicrob. Chemother. 54:134-138.
25. Wu, T. L., J. H. Chia, L. H. Su, C. Chu, A. J. Kuo, and C. H. Chiu. 2006. Dissemination of extended-spectrum beta-lactamase-producing Enterobacteriaceae in intensive care units of a medical center in Taiwan. Microb. Drug Resist. 12:203-209.
26. Ye, Y., J. B. Li, D. Q. Ye, and Z. J. Jiang. 2006. Enterobacter bacteremia: clinical features, risk factors for multiresistance and mortality in a Chinese University Hospital. Infection 34:252-257.
27. Yu, W. L., K. C. Cheng, C. J. Chi, H. E. Chen, Y. C. Chuang, and L. T. Wu. 2006. Characterisation and molecular epidemiology of extended-spectrum beta-lactamase-producing Enterobacter cloacae isolated from a district teaching hospital in Taiwan. Clin. Microbiol. Infect. 12:579-582.
28. Yu, W. L., Y. C. Chuang, and J. Walther-Rasmussen. 2006. Extended-spectrum beta-lactamases in Taiwan: epidemiology, detection, treatment and infection control. J. Microbiol. Immunol. Infect. 39:264-277.